4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-19-061545
President and CEO gave up 743 shares (to pay taxes)
- President and CEO acquired 2,925 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…